Tue. 14 May 2024, 4:07pm ET
Benzinga
Earnings, Earnings Beats, News
ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.27) by 3.7 percent. This is a 72.04 percent increase over losses of $(0.93) per share from the same period last year.